Octopus Biosafety SA (FR:MLOCT) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Octopus Biosafety SA has announced the resumption of its listing on Euronext Access Paris, effective December 16, 2024, following a commercial court’s decision to extend the observation period until May 2025. The company’s shares had been previously suspended due to a potential asset sale amid liquidation concerns.
For further insights into FR:MLOCT stock, check out TipRanks’ Stock Analysis page.